Finance

Lists
B8FK:FRA
Biofrontera AG
2,78 €
0,00%
(0,00) 1D
14 қаз., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for B8FK...
Open
2,78 €
High
2,78 €
Low
2,78 €
Mkt. cap
17,81 млн
Avg. vol.
171,00
Volume
0,00
P/E ratio
3,21
52-wk high
4,80 €
52-wk low
2,18 €
EPS
0,87 €
No. of employees
62
Open
2,78 €
High
2,78 €
Low
2,78 €
Mkt. cap
17,81 млн
Avg. vol.
171,00
Volume
0,00
P/E ratio
3,21
52-wk high
4,80 €
52-wk low
2,18 €
EPS
0,87 €
No. of employees
62
News stories
From web sources and news partners
About Biofrontera AG
CEO-
Employees62
Founded1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
3,55 млн
-
3,71 млн
5,32 млн
Cost of goods sold
1,15 млн
-
709,00 м.
1,01 млн
Cost of revenue
1,15 млн
-
709,00 м.
1,01 млн
Research and development expenses
1,20 млн
-
539,00 м.
601,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,20 млн
-
2,46 млн
2,26 млн
Operating expense
3,40 млн
-
3,00 млн
2,87 млн
Total operating expenses
4,56 млн
-
3,70 млн
3,87 млн
Operating income
-1,00 млн
-
9,00 мың
1,45 млн
Other non operating income
540,00 м.
-
38,00 мың
37,00 мың
EBT including unusual items
-369,00 м.
-
41,00 мың
1,47 млн
EBT excluding unusual items
-369,00 м.
-
41,00 мың
1,49 млн
Income tax expense
1,00 мың
-
-
4,00 мың
Effective tax rate
-0,27%
-
-
0,27%
Other operating expenses
-
-
-
-
Net income
-370,00 м.
-
2,20 млн
3,33 млн
Net profit margin
-10,41%
-
59,24%
62,60%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
6,00 мың
Interest expense
-1,00 мың
-
-6,00 мың
-
Net interest expenses
-1,00 мың
-
-6,00 мың
6,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-940,50 м.
-
54,75 мың
1,56 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары